These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 23196842)
1. Hippo-YAP and mTOR pathways collaborate to regulate organ size. Csibi A; Blenis J Nat Cell Biol; 2012 Dec; 14(12):1244-5. PubMed ID: 23196842 [TBL] [Abstract][Full Text] [Related]
2. YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29. Tumaneng K; Schlegelmilch K; Russell RC; Yimlamai D; Basnet H; Mahadevan N; Fitamant J; Bardeesy N; Camargo FD; Guan KL Nat Cell Biol; 2012 Dec; 14(12):1322-9. PubMed ID: 23143395 [TBL] [Abstract][Full Text] [Related]
3. Active epithelial Hippo signaling in idiopathic pulmonary fibrosis. Gokey JJ; Sridharan A; Xu Y; Green J; Carraro G; Stripp BR; Perl AT; Whitsett JA JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563341 [TBL] [Abstract][Full Text] [Related]
4. Hippo signaling regulates pancreas development through inactivation of Yap. George NM; Day CE; Boerner BP; Johnson RL; Sarvetnick NE Mol Cell Biol; 2012 Dec; 32(24):5116-28. PubMed ID: 23071096 [TBL] [Abstract][Full Text] [Related]
5. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung. Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985 [TBL] [Abstract][Full Text] [Related]
6. Targeting YAP and Hippo signaling pathway in liver cancer. Liu AM; Xu MZ; Chen J; Poon RT; Luk JM Expert Opin Ther Targets; 2010 Aug; 14(8):855-68. PubMed ID: 20545481 [TBL] [Abstract][Full Text] [Related]
7. Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis. Wu H; Wei L; Fan F; Ji S; Zhang S; Geng J; Hong L; Fan X; Chen Q; Tian J; Jiang M; Sun X; Jin C; Yin ZY; Liu Q; Zhang J; Qin F; Lin KH; Yu JS; Deng X; Wang HR; Zhao B; Johnson RL; Chen L; Zhou D Nat Commun; 2015 Feb; 6():6239. PubMed ID: 25695629 [TBL] [Abstract][Full Text] [Related]
8. The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma. Kong F; Li Y; Hu E; Wang R; Wang J; Liu J; Zhang J; He D; Xiao X PLoS One; 2016; 11(12):e0167080. PubMed ID: 27907036 [TBL] [Abstract][Full Text] [Related]
9. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer. Chen M; Zhang H; Shi Z; Li Y; Zhang X; Gao Z; Zhou L; Ma J; Xu Q; Guan J; Cheng Y; Jiao S; Zhou Z J Biol Chem; 2018 Sep; 293(37):14455-14469. PubMed ID: 30072378 [TBL] [Abstract][Full Text] [Related]
10. Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis. Kim W; Khan SK; Gvozdenovic-Jeremic J; Kim Y; Dahlman J; Kim H; Park O; Ishitani T; Jho EH; Gao B; Yang Y J Clin Invest; 2017 Jan; 127(1):137-152. PubMed ID: 27869648 [TBL] [Abstract][Full Text] [Related]
11. Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effector. Xu J; Li PX; Wu J; Gao YJ; Yin MX; Lin Y; Yang M; Chen DP; Sun HP; Liu ZB; Gu XC; Huang HL; Fu LL; Hu HM; He LL; Wu WQ; Fei ZL; Ji HB; Zhang L; Mei CL Clin Sci (Lond); 2016 Mar; 130(5):349-63. PubMed ID: 26574480 [TBL] [Abstract][Full Text] [Related]
13. Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway. Liu J; Li J; Li P; Wang Y; Liang Z; Jiang Y; Li J; Feng C; Wang R; Chen H; Zhou C; Zhang J; Yang J; Liu P Sci Rep; 2017 Feb; 7():42125. PubMed ID: 28169360 [TBL] [Abstract][Full Text] [Related]
14. LATS2 Inhibits Malignant Behaviors of Glioma Cells via Inactivating YAP. Shi Y; Geng D; Zhang Y; Zhao M; Wang Y; Jiang Y; Yu R; Zhou X J Mol Neurosci; 2019 May; 68(1):38-48. PubMed ID: 30771084 [TBL] [Abstract][Full Text] [Related]
16. Differential Levels of Hippo Signaling in Selected Brain and Peripheral Tissues in Streptozotocin-Induced Cognitive Dysfunction in Mice. Yu F; Han W; Zhan G; Li S; Jiang X; Xiang S; Zhu B; Yang L; Hua D; Luo A; Hua F; Yang C Neuroscience; 2019 Nov; 421():48-58. PubMed ID: 31682826 [TBL] [Abstract][Full Text] [Related]
17. Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway. Ehmer U; Sage J Mol Cancer Res; 2016 Feb; 14(2):127-40. PubMed ID: 26432795 [TBL] [Abstract][Full Text] [Related]
18. Targeting Mechanics-Induced Fibroblast Activation through CD44-RhoA-YAP Pathway Ameliorates Crystalline Silica-Induced Silicosis. Li S; Li C; Zhang Y; He X; Chen X; Zeng X; Liu F; Chen Y; Chen J Theranostics; 2019; 9(17):4993-5008. PubMed ID: 31410197 [TBL] [Abstract][Full Text] [Related]
19. Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration. Grijalva JL; Huizenga M; Mueller K; Rodriguez S; Brazzo J; Camargo F; Sadri-Vakili G; Vakili K Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G196-204. PubMed ID: 24875096 [TBL] [Abstract][Full Text] [Related]